NeuroScientific Biopharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
The webpage contains a free E,S&G report covering NeuroScientific Biopharmaceuticals Ltd. Browse to the end of this page for potential risks for NeuroScientific Biopharmaceuticals Ltd based on industry, location and marketcap. This Disclosure rating covers seventeen United Nations Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Partnerships for the Goals'.
NeuroScientific Biopharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 5.3 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | NeuroScientific Biopharmaceuticals Ltd | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does NeuroScientific Biopharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Does NeuroScientific Biopharmaceuticals Ltd disclose current and historical energy intensity?
Does NeuroScientific Biopharmaceuticals Ltd report the average age of the workforce?
Does NeuroScientific Biopharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Does NeuroScientific Biopharmaceuticals Ltd disclose its ethnicity pay gap?
Does NeuroScientific Biopharmaceuticals Ltd disclose cybersecurity risks?
Does NeuroScientific Biopharmaceuticals Ltd offer flexible work?
Does NeuroScientific Biopharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does NeuroScientific Biopharmaceuticals Ltd disclose the number of employees in R&D functions?
Does NeuroScientific Biopharmaceuticals Ltd conduct supply chain audits?
Does NeuroScientific Biopharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does NeuroScientific Biopharmaceuticals Ltd conduct 360 degree staff reviews?
Does NeuroScientific Biopharmaceuticals Ltd disclose the individual responsible for D&I?
Does NeuroScientific Biopharmaceuticals Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does NeuroScientific Biopharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Does NeuroScientific Biopharmaceuticals Ltd disclose water use targets?
Does NeuroScientific Biopharmaceuticals Ltd have careers partnerships with academic institutions?
Did NeuroScientific Biopharmaceuticals Ltd have a product recall in the last two years?
Does NeuroScientific Biopharmaceuticals Ltd disclose incidents of discrimination?
Does NeuroScientific Biopharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Has NeuroScientific Biopharmaceuticals Ltd issued a profit warning in the past 24 months?
Does NeuroScientific Biopharmaceuticals Ltd disclose parental leave metrics?
Does NeuroScientific Biopharmaceuticals Ltd disclose climate scenario or pathway analysis?
Does NeuroScientific Biopharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does NeuroScientific Biopharmaceuticals Ltd disclose the pay ratio of women to men?
Does NeuroScientific Biopharmaceuticals Ltd support suppliers with sustainability related research and development?
Does NeuroScientific Biopharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does NeuroScientific Biopharmaceuticals Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is NeuroScientific Biopharmaceuticals Ltd involved in embryonic stem cell research?
Does NeuroScientific Biopharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Does NeuroScientific Biopharmaceuticals Ltd disclose its waste policy?
Does NeuroScientific Biopharmaceuticals Ltd report according to TCFD requirements?
Does NeuroScientific Biopharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does NeuroScientific Biopharmaceuticals Ltd disclose energy use targets?
Does NeuroScientific Biopharmaceuticals Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does NeuroScientific Biopharmaceuticals Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for NeuroScientific Biopharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.